Hypothesis

3 Matching Annotations

Last 7 days
www.biorxiv.org www.biorxiv.org

EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming

1
1. scibot 11 Jun 2026
  
  in Public
  
  RRID:AB_2562994
  
  DOI: 10.64898/2026.06.01.725956
  
  Resource: (BioLegend Cat# 104911, RRID:AB_2562994)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2562994
  
  What is this?
  
  RRID:AB_2562994
Visit annotations in context

Tags

RRID:AB_2562994

Annotators

scibot

URL

biorxiv.org/content/10.64898/2026.06.01.725956v1
Jan 2023
www.sciencedirect.com www.sciencedirect.com

Neutrophil-activating therapy for the treatment of cancer

1
1. scibot 27 Jan 2023
  
  in Public
  
  RRID:AB_2562994
  
  DOI: 10.1016/j.ccell.2023.01.002
  
  Resource: (BioLegend Cat# 104911, RRID:AB_2562994)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2562994
  
  What is this?
  
  RRID:AB_2562994
Visit annotations in context

Tags

RRID:AB_2562994

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823000028
Jan 2020
www.sciencedirect.com www.sciencedirect.com

Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:AB_2562994
  
  DOI: 10.1016/j.celrep.2019.11.042
  
  Resource: (BioLegend Cat# 104911, RRID:AB_2562994)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_2562994
  
  What is this?
  
  RRID:AB_2562994 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:AB_2562994

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124719315244